Page last updated: 2024-11-07

pyrroxamycin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

pyrroxamycin: isolated from Streptomyces sp. S46506; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID129138
CHEBI ID188711
MeSH IDM0151621

Synonyms (24)

Synonym
(-)-2,3-dichloro-5-(6,8-dichloro-4h-1,3-benzodioxin-4-yl)-4-nitro-1h-pyrrole
al-r2081
1h-pyrrole, 2,3-dichloro-5-(6,8-dichloro-4h-1,3-benzodioxin-4-yl)-4-nitro-, (-)-
ll-f42248-alpha
4,5-dichloro-2-(6',8'-dichloro-4'-h-1,3-benzodioxin-4'-yl)-3-nitropyrrole
pyrroxamycin
from streptomyces mg796-af7
nsc619798
nsc-619798
dioxapyrrolomycin
105888-54-8
CHEBI:188711
2,3-dichloro-5-[(4s)-6,8-dichloro-4h-1,3-benzodioxin-4-yl]-4-nitro-1h-pyrrole
2,3-dichloro-5-(6,8-dichloro-4h-1,3-benzodioxin-4-yl)-4-nitro-1h-pyrrole
unii-v9axn5h81t
v9axn5h81t ,
2,3-dichloro-5-((4s)-6,8-dichloro-4h-1,3-benzodioxin-4-yl)-4-nitro-1h-pyrrole
ss-46506a
1h-pyrrole, 2,3-dichloro-5-((4s)-6,8-dichloro-4h-1,3-benzodioxin-4-yl)-4-nitro-
antibiotic al-r 2081
ll-f 42248.alpha.
Q27291695
DTXSID601140134
AKOS040749253

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzodioxineAny organic heterobicyclic compound containing ortho-fused benzene and dioxine rings.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (33.33)18.7374
1990's2 (22.22)18.2507
2000's3 (33.33)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]